BIOMAT Database Logo BIOMAT Database Logo

Clonal diversity among Burkholderia cepacia complex isolates from cystic fibrosis patients in a reference unit. 2013

Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Servicio de Microbiología Clínica, Hospital Universitario 12 de Octubre, Madrid, Spain.

BACKGROUND The epidemiology of Burkholderia cepacia complex (Bcc) in cystic fibrosis (CF) is not widely known. METHODS All CF patients with Bcc between 2002 and 2011 were reviewed, and a molecular analysis of isolates was performed. RESULTS The prevalence of Bcc infection was 7.2% (18/250). Molecular analysis of 16 Bcc isolates showed 5 species (7 B. contaminans, 6 B. cepacia, 1 B. cenocepacia, 1 B. multivorans, and 1 B. stabilis) and 13 sequence types. There were no cases of cross-transmission. CONCLUSIONS A high diversity of Bcc species was found in infected CF patients.

UI MeSH Term Description Entries
D008297 Male Males
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D042602 Burkholderia cepacia complex A group of phenotypically similar but genotypically distinct species (genomovars) in the genus BURKHOLDERIA. They are found in water, soil, and the rhizosphere of crop plants. They can act as opportunistic human pathogens and as plant growth promoting and biocontrol agents.
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.
July 2003, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis.
October 2004, Journal of clinical microbiology,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.
December 2017, Medical microbiology and immunology,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Burkholderia cepacia complex in Indian cystic fibrosis patients.
November 2012, The Indian journal of medical research,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
In vitro activity of doripenem against Burkholderia cepacia complex isolates from non-cystic fibrosis patients.
March 2011, Antimicrobial agents and chemotherapy,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.
January 2017, PloS one,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.
May 2007, Journal of clinical microbiology,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Burkholderia cepacia complex: clinical course in cystic fibrosis patients.
December 2015, BMC pulmonary medicine,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Burkholderia cepacia complex infection in patients with cystic fibrosis.
July 2002, Journal of medical microbiology,
Laura Barrado, and M Teresa Martinez, and Jennifer Villa, and M Ángeles Orellana, and Esther Viedma, and Fernando Chaves
Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
June 2005, Journal of clinical microbiology,
Copied contents to your clipboard!